CONTEXT AND OBJECTIVES: The incidence of acute leukemia (AL) subtypes varies according to geographical distribution. The aim here was to determine the incidence of morphological and immunophenotypic AL subtypes in the state of Maranhão, Brazil, and to correlate the expression of aberrant phenotypes in children with acute lymphoblastic leukemia (ALL) with prognostic factors. DESIGN AND SETTING: Single prospective cohort study at a public oncology reference center in Maranhão. METHODS: Seventy AL cases were diagnosed between September 2008 and January 2010. For the diagnosis, complete blood cell counts, myelograms (at diagnosis and at the end of the induction phase), cytochemical analysis and immunophenotyping were performed. RESULTS: Among adult patients (n = 22), the incidence of AL types was: ALL (22.7%) and acute myeloid leukemia (AML) (77.3%). The subtype AML M0 occurred most frequently (29.4%). In children (n = 48), the types were: AML (18.7%), most frequently subtype AML M4 (33.4%); biphenotypic acute leukemia (BAL) (4.2%); and ALL (77.1%), including the subtypes B-ALL (72.9%) and T-ALL (27.1%). Among the children with ALL, there were no statistically significant differences between patients with and without aberrant phenotypes, in relation to hematological parameters and treatment response. CONCLUSION: This work demonstrates that the frequencies of AML M0 cases among adults and T-ALL cases among children in Maranhão were high. This suggests that there may be differences in AML subtype incidence, as seen with ALL subtypes, in different regions of Brazil. No association was found between the expression of aberrant phenotypes and prognostic factors, in children with ALL. -T (27,1%). Na LLA, em crianças, não se encontrou diferença estatisticamente significante entre pacientes com e sem fenótipos aberrantes, em relação aos parâmetros hematológicos e resposta ao tratamento. CONCLUSÃO: Esta pesquisa demonstra elevada frequência de casos de LMA M0 em adultos, bem como das LLA-T em crianças no Maranhão, sugerindo que podem haver diferenças na incidência dos subtipos das LMA, assim como dos subtipos de LLA, em diferentes regiões do Brasil. Não foi encontrada associação entre a expressão de fenótipos aberrantes e fatores prognósticos em crianças com LLA.
INTRODUCTION
Acute leukemias comprise a heterogeneous group of diseases characterized by rapid and uncontrolled clonal expansion of progenitor cells of the hematopoietic system. 1 They are the most common form of childhood neoplasia, and acute lymphoblastic leukemia (ALL) represents 75% of all such cases. This percentage is much lower in adults, in whom acute myeloid leukemias (AMLs) are more common. In children, the vast majority of ALL cases (80%-85%) are of precursor B-lineage and about 15% of all cases are of T-lineage. 2, 3 A small number of patients whose blasts simultaneously present antigens of the myeloid and lymphoid lineages are characterized as carriers of mixed, hybrid or biphenotypic acute leukemias (BALs). 4, 5 AML and ALL in which the blasts contain one or two antigens of another lineage, but do not meet the criteria for BAL, are known respectively as acute myeloid leukemias with anomalous lymphoid expression and acute lymphoblastic leukemias with anomalous myeloid expression. 6, 7 Occurrence of aberrant phenotypes (or anomalous expression) are reported to have variable frequency and their prognostic value is controversial. 8 Early classification systems for acute leukemias were based only on cytomorphological and cytochemical investigations. porates not only immunophenotyping but also cytogenetic and molecular characteristics that contribute towards defining biologically and clinically relevant leukemia subsets. However, it is neither necessary nor cost-effective to perform multiple studies on every specimen. [9] [10] [11] Analysis of the incidence of leukemia subtypes across the world has revealed important variations in relation to geographical distribution, sex, age, ethnicity and socioeconomic status, thus suggesting that several etiological factors exist. 12, 13 Therefore, further studies on the frequencies of different subtypes of acute leukemias are of great importance, especially in regions with different socioeconomic characteristics such as the northeast of Brazil, where such data are scarce.
Unfortunately, before our group created an immunophenotyping service for the state of Maranhão, acute leukemias were not diagnosed through immunological markers, except in rare cases of patients whose relatives had the financial means to send their samples to a more advanced center. As a result, the vast majority of such patients were treated and given a prognosis on the basis of morphological and clinical findings alone, which may sometimes blur the choice of the most appropriate treatment.
OBJECTIVES
The aim of the present study was to determine the incidence of different morphological and immunophenotypic subtypes of acute leukemia among patients referred to an oncology reference center in the state of Maranhão for treatment of acute leukemias, and to correlate the expression of aberrant phenotypes in children with acute lymphoblastic leukemia (ALL) with prognostic factors.
METHODS

Sample and setting
The present investigation was approved by the Research Ethics take part or whose legal guardians did not allow their participation (n = 1) and cases of blast crisis chronic myeloid leukemia (n = 2) were excluded, thus resulting in 70 participants in this study. The following patient data were gathered: sex, age and occurrences of deaths of children with ALL before the end of the induction phase.
We evaluated the association between prognostic factors (white blood cell count, platelet count, hemoglobin level, peripheral blast percentage and response to treatment) and expression of aberrant phenotypes in children with ALL. This association could not be analyzed in cases of children (n = 9) and adults (n = 17) with AML, or among adults with ALL (n = 5), due to the small sample size.
Diagnosis
The diagnosis of acute leukemia was made based on the com- 
Remission criteria among children with ALL
The response to treatment among children with ALL was evaluated by means of a bone marrow aspirate smear at the end of the induction phase and the presence of less than 5% blasts in the bone marrow was considered to be a criterion for remission.
Patients who died before the end of the induction (n = 10) were considered to be patients who did not go into remission.
Statistical analysis
An initial exploratory and descriptive analysis of the data was and T-ALL, as well as between ALL and AML, were assessed by applying Fisher's exact test and the chi-square test. The significance level was taken to be 5% (P < 0.05) in all tests.
RESULTS
A total of 70 patients with de novo acute leukemia were studied. Table 1 shows the incidence of the types of leukemias in the population studied. ALL was more frequent in children (77.1%) and AML was more common in adults (77.3%). BAL accounted for 2.9% of the cases of acute leukemias.
B-ALL was found in 72.9% (27/37) of the cases of ALL in children, while T-ALL accounted for 27.1% (10/37) of the cases. The immunological subtype ALL-BII (common B) was the most frequent type (51.6%; 16/31) among the cases of B-ALL ( Table 2 ).
The median age of the children with B-ALL was four years (range from one to 16 years), while that of children with T-ALL was eight years (range from two to 17 years). The peak incidence of ALL in children occurred between the ages of one and four years, representing 40.5% (22/37) of the cases of ALL diagnosed in children. Among the adults, the median age of those with ALL was 24 years (range from 19 to 56 years). Among the patients under the age of 18 years with ALL, the male-to-female ratio was 3.1:1.0. For B-ALL and T-ALL considered separately, the ratios were 3.5:1.0 and 2.3:1.0, respectively.
The hematological characteristics of the subtypes of ALL are presented in Table 3 . It can be seen that T-ALL presented higher white cell counts, with a median greater than 50 x 10 9 /l. Regard- The distribution of AML according to the FAB criteria revealed that the AML M4 subtype (3/9; 33.4%) was the one most frequently occurring in children. In the adults, the predominant subtype was AML-M0 (5/17; 29.4%) ( Table 6 ).
The adult patients presented a median age of 35 years (range:
19-67 years), while the median age among the children was 8 years (range: 1-15 years). The ratio of males to females with AML was 1.3:1. Table 7 shows the hematological characteristics of the AML subtypes. It can be seen that AML-M1 presented a higher white blood cell count with a median of 50. There were aberrant phenotypes in 27% of the diagnosed cases, and expression of CD7 occurred most frequently (19.2%).
There was no statistically significant difference between ALL and AML in relation to the frequency of aberrant phenotypes (Table 8) .
DISCUSSION
This work constitutes the first study to be carried out in the state of Maranhão involving characterization of the immunophenotypic profile of cases of acute leukemias, and thereby determining the various immunological subtypes of these pathological conditions. The majority of ALL cases (88.1%) examined were diagnosed in children, and this matches the epidemiological data already described, which showed much lower frequencies of this neoplasia in adults. 18, 19 In the present investigation, the cases of ALL in adults represented just 22.7% of all the cases of acute leukemias in this age group.
The incidence of ALL is higher among men than among women, independent of the age group analyzed. In a study involving children from the states of Rio de Janeiro and Bahia and the Federal District, the ratio of males to females was 1.2:1. 13 In the state of Pernambuco, this ratio was 1.7:1, 20 while in Ribeirão Preto (city in the state of São Paulo), it was 1.8:1 for all subtypes of ALL,
with an even higher predominance of males for T-ALL, at 4.2:1.
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In our work, for all subtypes of ALL, we found a higher proportion of males (3.1:1) than what has been described in other Brazilian state of, with a higher male-to-female ratio for B-ALL (3.5:1) than for T-ALL (2.3:1).
In relation to the subtypes of ALL, the present study revealed that 73.8% of the cases were classified as B-ALL and 26.2% of the cases as T-ALL. Among the B-ALL subtypes, ALL-BII (common B) occurred most frequently. These results are similar to those of other studies, except for the high frequency of T-ALL in children. In the population of Maranhão, the children presented a higher frequency of T-ALL (27%) than what is generally described in the literature (7.3% to 16%). 13 
25
A high frequency of T-ALL is associated with poor socioeconomic conditions, as demonstrated by research conducted in Brazil, which found a direct association between poor socioeconomic status (low per capita income) and the T phenotype. 25 Another factor associated with increased frequency of T-ALL is ethnic origin, since the T phenotype has been shown to be more frequent among nonwhites. 13 Taking into consideration that the state of Maranhão is the second poorest in Brazil, 26 and that the population is predominantly nonwhite, 27 this may explain the high incidence of T-ALL found in the present investigation.
In relation to AML, our results show that this disease was much more frequent among adults (65.4%) than in children (34.6%), and this finding is in agreement with reports in the literature. 28 With regard to another aspect of our findings, taking into consideration all of the patients, our results indicate a much lower frequency of AML (37.1%) than of ALL (60%). A similar result was described by Rego et al., 18 who found that in the state of Piauí, the frequency of AML was half that of ALL.
In relation to the age of the patients with AML, the median obtained for the population of Maranhão was lower than that of patients with AML in developed countries, 29, 30 but was similar to that observed in other studies conducted in Brazil. 18, 31, 32 This can be explained by the fact that, in developed countries, life expectancy is higher and elderly individuals constitute a greater proportion of the population. This differs from Brazil, especially in the northeast of the country, where life expectancy is low and, consequently, the elderly population is much smaller, as reported by Rego et al. 18 Since the highest incidence of AML is seen in people over 60 years of age, 28 this may explain the low incidence of the disease in the population of Maranhão.
Analysis on the distribution of the FAB subtypes revealed predominance of AML-M4 followed by subtype AML-M1 in children. This result is similar to that found in research performed in São Paulo, 33 while a higher frequency of subtypes M2 and M3
was reported in Minas Gerais. 34 In contrast, work by the BerlinFrankfurt-Münster (BFM) group in Germany showed higher frequency of subtypes M4 and M5. 35 Among the adults, the most frequent subtype was M0, followed by subtypes M2 and M3, which presented equal frequency.
Aside from the M0 subtype, which is considered to be a less com- Other studies carried out in Brazil have indicated differences with regard to the distribution of morphological subtypes of acute leukemias. In comparison with rates in Campinas (state of São Paulo) and Teresina (state of Piauí), it was found that the most common subtype in Teresina was M2, followed by M4 and M5 with equal frequencies, while in Campinas there was higher frequency of the M4 subtype followed by the M3 subtype. 18 In São José dos Campos (state of São Paulo), there was higher prevalence of the M1 subtype, followed by M2. 37 In Rio de Janeiro, there was higher frequency of M2, followed by M3 and M4, which were equally frequent, 31 while in Rio Grande do Sul, higher frequency of M2 was found, followed by M1. 32 In the present study, the increased incidence of the FAB subtype M0 was based on samples obtained from a single institution.
It should be emphasized that the patients studied may not be representative of the whole region. Similar problems have affected other studies. 31, 32, 37 In addition, the majority of the studies 18, 31, 32 that have described the distribution of FAB morphological subtypes were retrospective, carried out by analyzing the medical records, many of which do not include immunophenotyping as a diagnostic technique for AML. In other cases, the immunophenotypic diagnosis was introduced a long time after the Den Boer et al. 41 and Bachir et al. 23 The frequency of myeloid coexpression was higher in B-ALL cases (48.4%) than in T-ALL cases (36.4%), although the difference was not significant. Den
Boer et al. 41 and Abdelhaleem 42 also found a higher frequency in B-ALL cases, but only the latter found the difference to be significant. In AML cases, there was anomalous expression in 26.9% of them, and the most frequent marker was CD7, thus confirming the findings of Zheng et al. 43 The association between prognostic factors and aberrant phenotypes in ALL in children remains controversial. Putti et al. 40 and Pui et al. 44 did not find any significant association with adverse prognostic factors. Riley et al. 45 stated that aberrant phenotypes in ALL, both in adults and in children, were significantly associated with short duration of event-free survival, short duration of first remission and high relapse rates within the treatment phase.
In our analysis of cases of ALL in individuals under the age of 18 years, there was no difference between patients with and without aberrant phenotypes in relation to prognostic factors, although the number of patients who achieved remission was greater in the group with anomalous expression. This is similar to the results found by Bhushan et al. 8 The literature shows great variation of data in relation to the frequency of anomalous expression in acute leukemia cases, and this may explain the lack of consistency with regard to the prognostic value of aberrant phenotypes in acute leukemia. Such variation may have multiple causes, including the use of different fluorochromes, the use of different clones of monoclonal antibodies, the sample characteristics, the technique and form of analysis used, the numbers and characteristics of patients, and the treatment protocol adopted.
CONCLUSION
The use of immunophenotyping in our study made it possible to diagnose cases of minimally differentiated acute myeloid leukemia (AML-M0) and to differentiate B-ALL from T-ALL.
The study showed that T-ALL and AML-M0 occurred at higher frequency in the population studied, thus suggesting that there may be differences in the incidence of the FAB subtypes of AML, as well as in the subtypes of ALL, in different regions of Brazil.
Furthermore, in all of these cases, the lack of immunophenotypic analysis could have compromised the diagnosis and, as a result, compromised the choice of the most appropriate treatment. We did not find any association between aberrant phenotypes and the prognostic factors and clinical outcomes. The evaluations on the parameters examined in this work, such as aberrant phenotypes, leukemia subtypes and patient survival, can be improved;
however, this requires longer duration of observation, and this should be borne in mind in future investigations.
